Information about Dissema Pharma
My details
*
*
*

Company information

Status
Active

Enterprise number

BE0659.809.737

VAT liability
Yes
Established
20-07-2016
Last balance sheet year
2024
Company size
Micro 0 FTE
Principal activity
Activities of holding companies
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

Try for free Discover more

7-day free trial, no credit card required.

Financial data from Dissema Pharma

2024 2023 2022 2021
Profit/Loss € 23,033 -46 % € 42,586 -42 % € 73,928 28 % € 57,600
Equity € 266,949 9 % € 243,915 21 % € 201,329 58 % € 127,401
Gross margin € 40,266 -35 % € 62,217 -41 % € 105,528 30 % € 81,187

Publications from Dissema Pharma

Date Publication
03-01-2024 Articles of Association (Translation, Coordination, Other Modifications,...) (FR)
27-07-2018 Registered Office (FR)
25-07-2016 Rubric Constitution (New Juridical Person, Opening Branch, etc...) (FR)

Frequently asked questions

What is the VAT number of Dissema Pharma?
The VAT number of Dissema Pharma is BE 0659.809.737.
Wat is the PEPPOL ID of Dissema Pharma?
The PEPPOL ID of Dissema Pharma is 0208:0659809737. Log in or start a free trial to see the full overview.
When was Dissema Pharma founded?
Dissema Pharma was founded on 20-07-2016.
What is the address of Dissema Pharma?
The current registered office of Dissema Pharma is located at Av. de Selliers de Moranville 61, 1082 Berchem-Sainte-Agathe.
When was the last time Dissema Pharma filed their annual financial statements?
The most recent financial statements of Dissema Pharma were filed on 04-08-2025.
How many employees does Dissema Pharma have?
There are currently no employees working at Dissema Pharma or no workforce information is available.
What is the annual turnover of Dissema Pharma?
At the time of its most recent financial statements, Dissema Pharma did not publish any turnover figures. Dissema Pharma reported a gross margin of €40,265.80.

Sources